| 2016 | | Hyponatremia in patients with systemic lupus erythematosus | 박세진, 서창희 |
| 2012 | | Induction of remission is difficult due to frequent relapse during tapering steroids in Korean patients with polymyalgia rheumatica | 김현아, 서창희 |
| 2019 | | Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial | 서창희 |
| 2015 | | Mean platelet volume in young children with urinary tract infection. | 박세진 |
| 2020 | | Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry | 김현아 |
| 2005 | | Rheumatoid factor is a marker of disease severity in Korean rheumatoid arthritis. | 남동호, 박해심, 서창희, 조재현 |
| 2015 | | Role of bone scan in the assessment of polymyositis/dermatomyositis. | 김현아, 서창희, 안영실, 정주양 |
| 2017 | | Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease | 권지은, 김현아, 서창희, 임현이, 정주양, 한재호 |
| 2014 | | Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease. | 김현아, 서창희, 전자영, 정주양 |
| 2012 | | Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease | 김현아, 서창희, 전자영 |
| 2019 | | The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still's disease | 권지은, 김현아, 서창희, 임현이, 정주양, 한재호 |
| 2017 | | The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still's disease: A STROBE-compliant retrospective observational analysis | 김현아, 서창희, 정주양 |
| 2012 | | Therapeutic responses and prognosis in adult-onset Still's disease | 김현아, 서창희 |
